The expression of inducible nitric oxide synthase (iNOS), major histocompatibility class II molecules (MHC-II), CD68, and the calcium-binding proteins S100A8 and S100A9 (also called MRP8 and MRP14, respectively) was assessed in lung tissues from cattle that succumbed to pneumonia. Expression patterns of these markers were related to the types of lung lesion. iNOS expression was only observed in lungs infected with Arcanobacterium pyogenes or Pasteurella haemolytica but not in lungs from cattle with subacute chronic interstitial pneumonia and acute interstitial pneumonia due to Escherichia coli infection. High levels of iNOS were expressed by cells (probably leukocytes) surrounding necrotic foci. Occasionally, iNOS was expressed by intraalveolar macrophages in viable parenchyma, by leukocytes within the airways, and by some chondrocytes in the supporting cartilage of bronchi. Cells expressing MHC-II were distributed relatively evenly throughout areas of inflammation and did not display any clear association with necrotic foci. Cell types expressing MHC-II included type II alveolar epithelial cells, spindle-shaped cells of the interstitium, cells in bronchus-associated lymphoid tissue, and leukocytes in lymph and blood vessels but largely excluded iNOS-positive cells. Likewise, CD68-positive cells were rarely positive for iNOS and were not confined to the areas surrounding necrotic tissue. As with MHC-II and CD68, there was little if any coexpression of iNOS and either of the S100 proteins tested. Thus, in cattle with necrotizing bronchopneumonia, iNOS-expressing cells were largely restricted to the cellular zone surrounding necrotic areas.
Nitric oxide (nitrogen monoxide, NO) is an important pleiotropic mediator involved in blood pressure control, neurotransmission, and host defense and in a variety of pathologic sequelae. 28 It is synthesized from L-arginine by various isoforms of NO synthase (NOS). 26, 34, 37 Of particular importance both in host defense and development of lesions is the inducible NOS isoenzyme (iNOS), which is expressed upon activation by macrophages and a broad array of other cells. 26, 34 Unlike the other NOS isoenzymes, iNOS is constitutively active once it is expressed, 26 which allows large quantities of NO to be synthesized for extended time periods. iNOS-mediated NO synthesis inhibits the growth of a variety of microorganisms, from RNA and DNA viruses to intracellular bacteria and protozoal parasites, 6, 8, 11, 19, 20, 22 but also contributes to pathologic sequelae such as protein nitration, 9 immunosuppression, 33 suppression of protein synthesis, 35 promotion of apoptosis, 5, 10, 14 degeneration of nerves, 21 dysregulation of blood flow, 28 and destruction of cartilaginous tissue. 32 The exact role of NO in a given lesion or disease is difficult to determine for several reasons: 1) NO is a highly diffusible molecule that reacts with a variety of targets either within the NO-generating cell or in close proximity, 9, 25 2) depending on the site, quantity, and kinetics of NO synthesis and coexpressed mediators, NO may be beneficial or detrimental to the host, 3) iNOS is regulated in a complex, species-specific manner, 2, 3, 15, 16 precluding an extrapolation from murine studies to other species, and 4) recent studies in ruminants have indicated that an extrapolation from cells stimulated in vitro to their stimulation in foci of infection in vivo is not possible. 18 This complexity calls for studies on iNOS expression in inflamed, necrotic, and/or infected tissue, which should allow a better understanding of the in vivo role of locally produced NO in host defense and lesion development.
Local expression of iNOS, major histocompatibility complex II cells (MHC-II), CD68 and the phagocyte markers S100A8 and S100A9 (also called MRP8 and MRP9, respectively 27 ) was investigated using immunohistochemical techniques in cases of spontaneous bovine pneumonia. Members of the S100 family of calcium-binding EF-handed proteins are expressed by myeloid cells, particularly after their activation. 13, 30 Although their function is hypothetical, at present, these proteins appear to be useful markers for subsets of both neutrophils and macrophages. The following questions were addressed: Is iNOS expressed in lung tissues of cattle suffering from various types of pneumoniae? If so, is there any relationship between iNOS expression and the causative agent or particular lung lesions? Do the iNOS-expressing cells coexpress other markers characteristic for cells involved in host defense? Our results indicate that strong iNOS expression in bronchopneumonia is restricted to cells surrounding necrotic tissue and that these cells coexpress some other markers at a low level.
Materials and Methods

Reagents
The following reagents were obtained from Sigma Chemical Co. (St. Louis, MO): Naphthol AS-MX phosphate, fast red TR, mounting medium, Mayer's hematoxylin, diaminobenzidine (DAB), Tween-20, and saponin. The human IgG was from the Swiss Serum and Vaccine Institute (Berne, Switzerland) . The polyclonal rabbit anti-murine iNOS antibodies were from Upstate Biotechnology (Lake Placid, NY). The monoclonal anti-ovine MHC-II (VPM54) antibody was generously provided by B. Blacklaws, Cambridge University (Cambridge, England). The monoclonal antibodies specific for human S100A8 (clone S13.67) and human S100A9 (clone S36.48) were provided by Biomedicals AG (Augst, Swizterland). These antibodies react strongly with subsets of cattle neutrophils and macrophages in cell cultures and in formalin-fixed tissues 18 (personal observation). The monoclonal anti-CD68 antibody (clone EBM11) was purchased from DAKO (Glostrup, Denmark). Biotin-conjugated goat anti-rabbit IgG (HϩL) and anti-mouse IgG ϩ IgM (HϩL) were from Jackson Immunochemicals (West Grove, PA). Reagents for the avidin-biotin complex (ABC) immunocytochemical peroxidase and alkaline phosphatase staining procedures were from Vector Laboratories (Burlingame, CA).
Criteria for selection of lung tissue specimens
Lung tissues with a diagnosis of pneumonia were selected from the archives of the Institute for Animal Pathology of the University of Berne and categorized according to the causative agent. Pasteurella haemolytica, Arcanobacterium pyogenes (former names Actinomyces pyogenes, Corynebacterium pyogenes) and Escherichia coli were the most frequent microbial causes of pneumonia (Table 1 ). Six A. pyogenes-infected and an equal number of P. haemolytica-infected lung specimens were selected. For both of these categories, half of the lung specimens were from newborn calves (Յ3 weeks of age) and the other half were from weaned animals (2.5-5 months of age). The four E. coliinfected specimens were all from newborn calves. iNOS expression was also examined in the lungs of animals that had succumbed to subacute to chronic interstitial pneumonia. However, because of the small number of specimens retrievable from the archive, it was impossible to assemble a group of animals of comparable age in this category. Therefore, lung specimens from the four animals that were available were included regardless of their ages. Further details on all lung tissue specimens are provided in Table 1 .
Numbered serial sections were cut from the formalin-fixed, paraffin-embedded tissues and mounted on positively charged Super Frost Plus slides. The first of the serial sections was stained with hematoxylin and eosin, and the others were used for immunohistochemical staining.
Immunohistochemical staining procedure
Deparaffinized tissue sections were treated with 6% H 2 O 2 and 0.1% NaN 3 in phosphate-buffered saline (PBS) to quench the endogenous peroxidase activity in tissue sections and with human IgG (8 mg/ml) in enzyme-linked immunosorbent assay (ELISA) buffer (0.25 M NaCl, 20 mM Tris, 0.125% Tween-20; pH 7.5) to block Fc receptors. The cell membranes were perforated by precincubation (15 minutes) in PBS containing 0.1% saponin. Sections were exposed for 1.5 hours at 37 C to primary antibodies at a 50-fold dilution in PPS/saponin (polyclonal anti-iNOS), at a 15-fold dilution (monoclonal anti-MHC-II), or at a 100-fold dilution (monoclonal anti-S100A8 and anti-S100A9). Then, sections were incubated for 45 minutes at 37 C with either an anti-rabbit (iNOS) or anti-mouse (all other primary antibodies) antibody diluted 200-fold in ELISA buffer. Slides were then incubated for 30 minutes at ambient temperature with the ABC reagents for either a peroxidase or alkaline phosphatase-based detection method. The peroxidase substrate was DAB (0.5 mg/ml in 100 mM Tris, pH 8.0, containing 0.01% H 2 O 2 ), and the alkaline phosphatase substrate was fast red (1 mg/ ml in 100 mM Tris pH 8.0 containing 0.5 mg/ml Naphthol 
* Frequency of positive cells. ϩϩϩ ϭ high frequency (readily seen with low-power magnification); ϩϩ ϭ medium frequency (mediumpower magnification used for confirmation); ϩ ϭ low frequency (only detectable with medium or high-power magnification); Ϫ ϭ absent; n.a. ϭ not applicable; MF ϭ multifocal distribution, including area immediately surrounding necrotic focus.
† Chondrocytes in bronchial cartilage. ‡ BALT ϭ bronchus-associated lymphoid tissue.
ASMX phosphate). Slides were counterstained with hematoxylin. Some slides were stained sequentially for iNOS and for one of the cell surface markers, MHC-II, CD68, S100A8, or S1000A9. To assess the specificity of immunostaining, sections of bovine brain tissue previously shown to contain iNOS-positive cells 18 were used as a positive control for iNOS. Negative control slides were stained in the absence of primary antibodies.
Evaluation of stained slides
iNOS, MHC-II, CD68, and S100 protein expression was assessed in terms of the abundance and anatomic location of cells expressing these markers and the relationship between marker expression and particular morphologic lesions. The frequency of positive cells was recorded semiquantitatively (see Table 2 ). Selected slides were evaluated independently by two observers, and discrepancies were clarified during a joint session.
Results
Histology
Multifocal necrosis and the presence of degenerating leukocytes and fibrin deposits were consistent features in tissue sections from five of six animals infected with A. pyogenes ( Fig. 1 ) and all animals in-fected with P. haemolytica (Fig. 2) . The necrotic foci were not contained by interlobular septa, and they consisted of either structurally preserved, coagulated tissue or lysed tissue that was replaced by a dense proteinaceous material. Occasionally, nuclear debris and/ or bacterial colonies were observed in necrotic foci.
Surrounding the necrotic foci in A. pyogenes-and P. haemolytica-infected tissues was a zone of degenerating leukocytes, oat-shaped cells, and/or fibrin deposits ( Figs. 1, 2) . The width and density of this zone differed between the two types of bacterial infections. In four of five A. pyogenes-infected lungs, this zone was very thin (less than one alveolus in width), and it typically surrounded lysed tissue that was replaced by a dense proteinaceous material (Fig. 1) . In five of six P. haemolytica-infected lungs, the zone encompassed several alveoli filled with tightly packed leukocytes (Fig. 2) . Furthermore, the alveolar infiltrate in viable tissue consisted of densely packed neutrophils and macrophages in the three lungs of the 1-2-week-old calves infected with P. haemolytica but only a moderate infiltrate in all lungs of animals infected with A. pyogenes and the three 21-week-old animals infected There is a focal necrosis in the bronchiolar epithelium (A ϭ epithelium, B ϭ focal necrosis). iNOS-positive cells and S100A8-positive cells within the necrosis and the bronchiolar lumen and more S100A8-positive cells surrounding the bronchiole, but there are hardly any double-labeled cells. Immunohistochemical double staining for iNOS (red) and S100A8 (brown). Bar ϭ 30 m.
with P. haemolytica. Multinucleated cells were present in alveoli of animals from both groups.
The airways of A. pyogenes-and P. haemolyticainfected lungs were filled with numerous degenerating neutrophils and lesser numbers of macrophages and occasionally contained bacterial colonies embedded in a dense proteinaceous material. The airway epithelium was often necrotic, regardless of the causative agent.
In five of six P. haemolytica-infected animals and in four of six animals infected with A. pyogenes, the interlobular septa appeared edematous and contained neutrophilic and monocytic infiltrates of variable density. In addition, the lymphatics of these interlobular septa were distended by protein-rich lymph.
Lesions in lungs, from which E. coli was isolated, consisted of hyperemia, alveolar edema, and multifocal hemorrhage. Small numbers of neutrophils and occasionally macrophages were present within alveoli. In one calf (No. 15), there was a considerable accumulation within the aveoli of macrophages containing a yellow pigment, probably due to intrauterine aspiration of amniotic fluid. In another E. coli-infected calf (No. 14), a diffuse, mild infiltration of neutrophils and monocytes into the interlobular septa and alveolar walls was observed. In addition, some fibrin thrombi were present in this calf.
The lungs of calves diagnosed with subacute interstitial pneumonia were characterized by the presence of hyaline membranes in alveoli, hypercellularity of alveolar walls, and type II pneumocyte hyperplasia.
Expression of iNOS
Significant iNOS expression was only observed in lung tissue from animals suffering from bronchopneumonia with multifocal necrosis ( Table 2 ). In lungs from which A. pyogenes was isolated, the narrow zone encircling necrotic foci contained a considerable number of cells strongly expressing iNOS (Fig. 3) . iNOS was also expressed by some cells within alveoli and airways in less-damaged areas of inflamed tissue and by some chondrocytes in the supportive cartilage of bronchi ( Table 2 ). Bronchopneumonia caused by P. haemolytica was also characterized by the presence of considerable numbers of iNOS-expressing cells in the zones surrounding necrotic foci (Table 2, Fig. 4 ). The frequency of iNOS-expressing cells in these zones, however, was lower than that observed in A. pyogenesinfected lungs. iNOS was also expressed by scattered cells within nonnecrotic alveoli and bronchioles.
Although tissues from calves infected with E. coli often contained an infiltrate rich in leukocytes, iNOS was not expressed in any of these calves ( Table 2) . Neither was iNOS expressed in any of the lungs of animals that were diagnosed with subacute interstitial pneumonia. No necrotic foci were detected in these lungs ( Table 2) . Thus, iNOS appears to be mainly expressed in the lungs of cattle with necrotizing bronchopneumonia caused by A. pyogenes or P. haemolytica.
To further characterize the iNOS-expressing cells, slides were stained with a variety of surface markers, and double-stained slides for both iNOS and surface markers were prepared.
Expression of MHC-II
In A. pyogenes-infected lungs, there was scattered MHC-II expression in the aveoli and alveolar interstitium throughout the tissue sections ( Table 2) . Some leukocytes in bronchus-associated lymphoid tissue and within blood vessels and lymphatics expressed MHC-II. Some cells in the bronchiolar epithelium also expressed MHC-II. Although most of these cells appeared to be true bronchiolar epithelial cells, some may have been leukocytes that were traversing the bronchiolar epithelium. In general, MHC-II expression did not show any association with necrotic foci as did iNOS (Fig. 3) . Although a few large intraalveolar cells coexpressed iNOS and MHC-II, these markers were generally expressed separately.
Expression of MHC-II in P. haemolytica-infected tissues was localized similarly and was of similar intensity to that observed in A. pyogenes-infected tissues ( Table 2 , Fig. 4 ). In one P. haemolytica-infected animal (No. 11), there was considerable proliferation of type-II pneumocytes. These cells showed strong MHC-II expression throughout the tissue section ( Fig.  5 ). There was very little if any interstitial MHC-II expression in the P. haemolytica-infected animals. Again, there was little if any expression of MHC-II in areas surrounding necrotic tissue, and there was virtually no coexpression of iNOS and MHC-II (Fig. 4) .
In lung tissues from E. coli-infected calves, MHC-II was localized similarly as described for animals infected with A. pyogenes and P. haemolytica, but MHC-II was generally expressed less abundantly (Table 2). In subacute to chronic interstitial pneumonia, type-II pneumocytes and cells in the alveolar interstitium appeared to be the major sources of MHC-II expression. Additionally, some leukocytes within alveoli and a few leukocytes in blood vessels and lymphatic vessels expressed MHC-II.
Expression of CD68
CD68 was detected mostly in cells within alveoli and within the interstitium. The tightly packed leukocytes in alveoli surrounding foci of necrosis (oat cells) were mostly negative for CD68 ( Table 2) . Numerous spindle-shaped cells in the interstitium and large numbers of cells of macrophage-like appearance within less severely affected alveoli were positive for this marker (Table 2, Fig. 6 ), but it was apparently not always coexpressed with MHC-II. There were alveoli with numerous CD68-positive cells ( Table 2 , Fig. 6 ), but hardly any MHC-II positive cells, and this protein could not be localized on type-II pneumocytes, which were MHC-II positive (cf. Figs. 5, 6 ).
Expression of S100A8 and S100A9
There was generally little difference in the anatomic location and abundance of S100A8 and S100A9 protein expression. In fact, the expression patterns were so similar that it is likely that these proteins were often coexpressed by individual cells. However, we were unable to study this with the tools available to us.
The abundance and localization of S100 protein expression was similar in lung tissues from animals infected with A. pyogenes and P. haemolytica ( Table 2 ). In both cases, they were typically expressed by cells with neutrophil and macrophage morphology within airways and aveoli. In addition, a few S100-positive cells were present in the alveolar interstitium and within blood vessels and lymphatic ducts throughout tissue sections. In alveoli showing a strong leukocyte infiltration with degenerating leukocytes (oat cells), virtually all the infiltrating leukocytes expressed S100 proteins ( Fig. 7) . Overall, there was very little coexpression of the S100 proteins and iNOS (Fig 8) .
The S100 proteins were expressed by a high number of cells in E. coli-infected lungs. S100-expressing cells were typically found in the alveolar wall and within alveoli. Although there were very few cells present within the airways, the majority of cells expressed one of the S100 proteins. Very little expression was observed in lung tissues from calves with subacute interstitial pneumonia.
Discussion and Conclusions
The expression of iNOS in the lungs of cattle with various types of pneumonia was addressed. iNOS was strongly expressed in lungs from cattle with bronchopneumonia and multifocal necrosis due to infection with A. pyogenes and P. haemolytica but not in lungs from animals with acute interstitial pneumonia due to E. coli infection and with subacute to chronic interstitial pneumonia. Expression of iNOS is typically seen at the transition from viable to necrotic tissue. This zone was narrower and contained a higher proportion of cells expressing iNOS in A. pyogenes-than in P. haemolytica-infected lungs. These two lesional patterns were remarkably similar to the lung lesions previously described. 12 The large majority of iNOS-expressing cells did not express MHC-II, CD68, S100A8, and S100A9.
Induction and regulation of iNOS has been extensively studied in cell culture in various species including cattle, and transcriptional control of iNOS has been addressed. Collectively, these studies suggest 1) that proinflammatory cytokines, microbial compounds, and hypoxia 24 induce or upregulate iNOS expression, 2) that transcription factors such as NF-kB and interferon-gamma (IFN-␥)-dependent constituents have a key role as transcriptional activators of iNOS, 23, 31, 36 and 3) that significant differences in iNOS induction exist among different cell types of a given species, 4, 15, 29 among identical cell types of different species, and between iNOS induction in vitro and in vivo. 18 Thus, it is difficult to speculate on the control of iNOS expression in vivo, making studies of iNOS expression in vivo in infected and/or inflamed tissues necessary. In necrotizing pneumonia of cattle, there is a characteristic localization at the above transition zone between viable and necrotic tissue. iNOS expression was not seen or was infrequently seen in other areas of the lung. Coexpression of candidate factors possibly contributing to iNOS induction/upregulation should be examined.
In vivo studies on iNOS expression in domestic animals are not numerous. iNOS expression in bacteriainduced bronchopneumonia can be compared with expression in a bacterial infection of the central nervous system, listeric encephalitis. 18 The similarities of the two types of infection include a stringent spatial confinement of iNOS expression and low levels of MHC-II and S100 protein expression by iNOS-positive cells. The major difference between the two models is that in the brain, the iNOS-expressing cell subset was completely contained within the CD68-positive cell set, i.e., within the mononuclear phagocyte subset, which did not appear to be the case in bacterial infections of the lung. It is not clear to which cell types the iNOSpositive, CD68-negative cells in the lung belong. Using the same CD68-specific antibody, other researchers found that the vast majority of degenerate oat cells were CD68 negative and tentatively concluded that they were neutrophils. 1 However, lacking a specific neutrophil criterion for fixed bovine tissues other than morphology, this question remains unsettled. An equally likely explanation is that lineage-specific markers are no longer expressed as a consequence of the progressed degeneration. Based on morphologic criteria, neutrophils in listeric encephalitis are negative for iNOS. 18 It is unclear whether these differences are site specific or are determined by structural or biologic features of the bacteria.
The highly restricted nature of iNOS expression in cattle pneumonia may be interpreted in several ways. Techniques such as the use of formalin-fixed, paraffin-embedded tissues or a weakend response due to assessment of a species heterologous to the iNOSantibody-inducing antigen may be factors affecting iNOS expression. However, these factors would not invalidate our finding that the iNOS expression by cells surrounding necrotic areas is much stronger than that by any other cells of the lungs examined and that these cells are low in expression of MHC-II, members of the S100 family of Ca 2ϩ -binding proteins, and CD68.
Both iNOS and MHC-II are expected to be upregulated by IFN-␥, based on in vitro studies with macrophages and other cells. 3, 7, 17, 23 Exclusive expression in vivo points to distinct or additional factors required for expression of either iNOS or MHC-II. Regulation of S100 protein expression is less well characterized. Macrophages cultured in vitro show clearly distinct induction patterns for S100A8 and S100A9 (Jungi, personal observation). In vivo, the two markers show a similar histologic distribution, although double staining has not been performed. The correlation between the frequency of S100-expressing cells and the severity of inflammation/tissue destruction confirms that in cattle these markers are induced rather than constitutive. Studies in other species suggest that their expression is restricted to subsets of neutrophils and mononuclear phagocytes. 13, 30 Although their function is at present not clear, they may for the purpose of this study be regarded as markers indicating certain subsets of activated phagocytes. It is intriguing in this context that iNOS is not coexpressed in these cell subsets.
These data demonstrate that iNOS is expressed in histopathologically clearly defined areas adjacent to necrotic foci in bronchopneumonia due to a gram-positive and a gram-negative bovine pathogen. Further studies are needed to delineate the exact cell type(s) involved, the factors governing iNOS expression, the relationship between iNOS expression and local NO generation, and a potential contribution of NO to blood supply and antimicrobial activity and to pathologic sequelae.
